These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36160032)

  • 1. Quantitative Expression of
    Rishehri M; Etemadi T; Pisheh L; Koufigar G; Azadeh M
    Genet Res (Camb); 2022; 2022():6787791. PubMed ID: 36160032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JHDM1D-AS1-driven inhibition of miR-940 releases ARTN expression to induce breast carcinogenesis.
    Zuo Y; Ma M; Wen Y; Chang L; Qu C
    Clin Transl Oncol; 2023 Jul; 25(7):2192-2203. PubMed ID: 36862282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer.
    Mehrpour Layeghi S; Arabpour M; Shakoori A; Naghizadeh MM; Mansoori Y; Tavakkoly Bazzaz J; Esmaeili R
    J Transl Med; 2021 Aug; 19(1):364. PubMed ID: 34446052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches.
    Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A
    Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA MIF-AS1 promotes breast cancer cell proliferation, migration and EMT process through regulating miR-1249-3p/HOXB8 axis.
    Ding J; Wu W; Yang J; Wu M
    Pathol Res Pract; 2019 Jul; 215(7):152376. PubMed ID: 31097355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA ARAP1-AS1 accelerates cell proliferation and migration in breast cancer through miR-2110/HDAC2/PLIN1 axis.
    Lu C; Wang X; Zhao X; Xin Y; Liu C
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32110804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
    Yang J; Wu W; Wu M; Ding J
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
    Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
    Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of long noncoding RNA B4GALT1-AS1 is associated with breast cancer development.
    Ahvaz S; Amini M; Yari A; Baradaran B; Jebelli A; Mokhtarzadeh A
    Sci Rep; 2024 Feb; 14(1):3114. PubMed ID: 38326326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.
    Bao G; Huang J; Pan W; Li X; Zhou T
    Cancer Med; 2020 Jan; 9(1):278-289. PubMed ID: 31701672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of FAM170B-AS1, hsa-miR-1202, and hsa-miR-146a-5p in breast cancer.
    Abd ELhafeez AS; Ghanem HM; Swellam M; Taha AM
    Cancer Biomark; 2024; 39(4):313-333. PubMed ID: 38250762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641.
    Zhong Y; Zeng W
    J Healthc Eng; 2022; 2022():6778199. PubMed ID: 35083026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
    Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
    Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of long non-coding RNA ZEB2-AS1 and EMT-related markers in ductal and lobular breast cancer.
    Zarei M; Malekzadeh K; Omidi M; Mousavi P
    Cancer Rep (Hoboken); 2023 May; 6(5):e1826. PubMed ID: 37088469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification and in vitro evaluation of MRPS30-DT lncRNA and MRPS30 gene expression in breast cancer.
    Shirani N; Mahdi-Esferizi R; Eshraghi Samani R; Tahmasebian S; Yaghoobi H
    Cancer Rep (Hoboken); 2024 Jun; 7(6):e2114. PubMed ID: 38886335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA
    Chen D; Chen J; Gao J; Zhang Y; Ma Y; Wei W; Wei Y
    Cancer Biother Radiopharm; 2020 Jun; 35(5):319-328. PubMed ID: 32412777
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
    Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G
    J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.